Back to search
FDAFDA · Food and drugs·Recall number D-0436-2020

Ofloxacin Ophthalmic Solution, USP, 0.3%, 5 mL, Rx only, Altaire Pharmaceuticals, Inc., NDC 59390-140-05

Published November 27, 2019 · Recall initiated: July 2, 2019

Summary

FDA records drug Class II recall D-0436-2020, published November 27, 2019 and initiated July 2, 2019. Recalling firm: Altaire Pharmaceuticals, Inc.; Status: Completed; Reported quantity: 102,939 units; Lot: 17244 8/19 18057 3/20 518307 12/20. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Completed — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Lack of Assurance of Sterility

What to do

Voluntary: Firm initiated · Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit

Get an email if OFLOXACIN OPHTHALMIC has another recall

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Brand
OFLOXACIN OPHTHALMIC
Manufacturer
Altaire Pharmaceuticals, Inc.
Distributor
U.S.A. Nationwide
UPC
593901400517
Lot
17244 8/19 18057 3/20 518307 12/20
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Ofloxacin Ophthalmic Solution, USP, 0.3%, 5 mL, Rx only, Altaire Pharmaceuticals, Inc., NDC 59390-140-05 recalled?

Yes. FDA published recall D-0436-2020 on November 27, 2019. Reported hazard: Lack of Assurance of Sterility

What should I do if I have this product?

Voluntary: Firm initiated · Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit

How do I know if my unit is part of the recall?

Compare your product details with the notice. Brand: OFLOXACIN OPHTHALMIC. UPC: 593901400517.